MedTrace Logo

Effects of Lower Body EMS Training in Postmenopausal Women

NCT07385534 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2026-02-04

No results posted yet for this study

Summary

This study evaluates the effects of a 6-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women.

Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these conditions, participation rates among postmenopausal women are often low. This study investigates whether applying EMS during lower body resistance exercises provides superior benefits compared to resistance training alone or no intervention.

Participants will be randomized into three groups:

1. Lower-body EMS combined with Resistance Training Group
2. Resistance Training Only Group
3. Control Group (No intervention)

The study aims to verify the efficacy of EMS as a time-efficient and effective alternative exercise modality for improving vascular and musculoskeletal health in this population.

Conditions

  • Sarcopenia
  • Arteriosclerosis
  • Arterial Stiffness, Blood Pressure
  • Postmenopausal Women

Interventions

DEVICE

Lower-body Electromyostimulation (LB-EMS) device

Electrical stimulation applied to the lower body muscles (85Hz, 350µs) during the main exercise phase

BEHAVIORAL

Lower Body Resistance Training

A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main lower body resistance training (4 types of machine-based exercises per session), and a 10-minute cool-down

Sponsors & Collaborators

  • Seoul National University

    lead OTHER

Principal Investigators

  • Yeon Soo Kim, MD · Seoul National University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-26
Primary Completion
2026-03-26
Completion
2026-05-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07385534 on ClinicalTrials.gov